|
Contact Information |
MyEyeDr. Jami Sowers 919.459.6463 Contact myeyedr.com |
Everyday Living® Your information source for products, shopping, marketing and business services, health matters, home and garden, food and lesiure, weight loss, anti-ageing surgical procedures and non-surgical rejuvenation treatments. www.everydayliving.com®
|
Contact Information |
MyEyeDr. Jami Sowers 919.459.6463 Contact myeyedr.com |
The Canadian Health
Coalition is a public advocacy organization dedicated to the protection
and improvement of Medicare. You can learn more about our work at healthcoalition.ca.
|
Ottawa, April, 2018: The
Canadian Health Coalition, which represents health care advocates
across the country, applauds the Parliamentary Committee on Health
(HESA) on its report on a national public drug plan: Pharmacare Now: Prescription Medicine Coverage for all Canadians.
"It should be acted on as soon as possible", said CHC Chair Pauline Worsfold, RN. "Bravo!
The Committee has not just recommended improved, universal public drug
coverage for all Canadians, but has given us a clear road map for how to
get there."
The recommendations provide a detailed guide for a
federal-provincial-territorial drug plan that would include everyone.
The Canada Health Act that now provides public health care for doctors
and hospitals would be expanded to include prescription drugs. This
would also mean a significant financial contribution by the federal
government to the cost.
The committee also proposes serious improvements to the
protection of Canadians from the self-interest of pharmaceutical
companies. New drugs would be evaluated by an independent government
agency free of influence by pharmaceutical companies. There would also
be a new national data collection to collect and review adverse drug
reactions.
The Committee also recommends transparent negotiations with
the drug companies over prices, building on the work of the pan-Canadian
Alliance, but with the important additional bargaining strength of
covering the whole population.
What does all this mean? It means public drug coverage for
all Canadians, as now exists for doctors and hospitals. It means an end
to different access to drugs depending where you live and work. It means
an effective process to negotiate drug prices with pharmaceutical
companies, reducing costs to a more reasonable level.
-30-
For more information, please contact:
James Hutt
National Director, Policy and Advocacy (Interim)
343-777-6283policy@healthcoalition.ca |
We should stop demonizing private clinics - and the patients who need them - and recognize that they're part of the solution
By Bacchus Barua
Associate director Centre for Health Policy Studies The Fraser Institute
Day,
a former head of the Canadian Medical Association, is fighting to allow
privately-funded treatment for patients who the public system has
failed.
Just a few days later, data from the Canadian Institute of Health Information (CIHI) reported that about one-third
of patients in B.C. did not receive joint replacements and cataract
surgeries within the remarkably long government benchmarks. And it's
getting worse.
These
events have again raised the contentious topic of patient cost-sharing
and the appropriate role of the private sector within, and alongside, a
universal health-care system.
Unfortunately, defenders of the status quo
have misled Canadians into believing that to maintain universal health
care, patients should neither expect to share in the cost of their
treatment nor use their financial resources to access treatment outside
the public system.
And
yet a glance around the world reveals that private-sector options and
cost-sharing are norms, not exceptions, in successful universal
health-care countries.
A recent Fraser Institute study
compared Canada's approach to universal health care with systems in
Australia, France, Germany, the Netherlands, New Zealand, Sweden,
Switzerland and the United Kingdom. Each of these countries share the
same goal of universal access to care, spend about same as Canada (some
more, some less) but have remarkably shorter wait times.
And
most of these countries embrace the private sector as a fundamental
part of their universal health-care framework. In the Netherlands, for
example, individuals are expected to purchase health insurance from
private (including for-profit) insurers in a regulated but competitive
market.
More
than one-third of hospitals in Germany operate on a for-profit basis
but are generally also accessible by patients with public insurance.
Even
the U.K. has a robust parallel private system, often used as an
alternative to the ailing public National Health Service (NHS). In fact,
Prince Philip recently received a hip replacement at a private facility
and questions have been raised about whether the NHS, which has long waiting lists, would have even treated someone his age.
All
these countries except the U.K. accept cost-sharing as a normal part of
universal health care. Cost-sharing establishes the right incentives to
ensure patients make more informed decisions about when and where to
use scarce medical resources.
Patients
in Switzerland can expect to pay the first 300 franc (equal to roughly
C$390) of their medical bills before insurance kicks in - and 10 per
cent of the cost of their treatment, up to a maximum of 700 franc per
year.
In Australia, although much was made of the government's recent see-saw on the question of a $7 fee for general practitioner visits, patients can still expect to pay about 15 per cent of the cost of specialist visits (sometimes more, if doctors charge above the government rate).
Of
course, all the countries examined protect vulnerable groups, and
therefore either exempt certain populations from payments (children,
mothers), provide a government safety net or set annual ceilings on
out-of-pocket expenses.
Only
in Canada are doctors threatened with fines for looking after patients
privately and outside of the government-funded system, while patients
are made to feel guilty for paying for their own treatment. In no other
successful universal health-care system does government step between
doctor and patient, and forbid doctors from providing medically
necessary treatment.
Of
course, if our governments provided timely access to care, patients
would be less inclined to pay for treatment. However, that's not the
case. Data from the Fraser Institute's annual survey of wait times reveal that patients are waiting longer than ever.
Until
governments in Canada realize that the private sector and patient
cost-sharing are a normal part of universal health care, Canadians will
likely continue to wait for the treatment they need within the confines
of the only system available.
Bacchus Barua is associate director of the Fraser Institute's Centre for Health Policy Studies. |